OR WAIT null SECS
November 30, 2023
Exagamglogene autotemcel seen as synechdoche.
November 20, 2023
Consent decrees were issued against Evig LLC, of St. George, Utah, and Premium Production LLC, of St. George, Utah, for unapproved dietary supplements.
The US District Court for the District of Arizona entered into consent decree against Smart Women’s Choice and its CEO to stop the company from distributing unapproved contraceptive drugs.
November 14, 2023
Adzynma provides a replacement for low levels of the ADAMTS13 enzyme in patients with congenital thrombotic thrombocytopenic purpura.
November 13, 2023
Recommended medicines include treatments for generalized myasthenia gravis, glioma, neovascular age-related macular degeneration, and more.
November 09, 2023
The document includes recommendations for the reporting and implementation of changes to container closure system components.
November 03, 2023
This is the second biologic approved to treat HS, a painful and reoccurring skin disease.
November 01, 2023
The guidance describes the agency’s procedures for performing remote interactive evaluations at drug manufacturing and bioresearch monitoring facilities.
October 30, 2023
PENBRAYA combines components from two meningococcal vaccines, Trumenba and Nimenrix.
October 26, 2023
The treatment has received Priority Review designation, as well as FDA Breakthrough Therapy designation and Orphan Drug designation.